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Abstract
Background: Tobacco smoke exposure impairs the lung’s innate immune response, leading to an increased risk of
chronic infections. SPLUNC1 is a secreted, multifunctional innate defense protein that has antimicrobial activity
against Gram negative organisms. We hypothesize that tobacco smoke-induced SPLUNC1 dysfunction contributes
to the observed defect in innate immunity in tobacco smokers and that this dysfunction can be used as a potential
biomarker of harm.
Methods: We collected sputum from never-smokers and otherwise healthy smokers. We performed Western
blotting to determine SPLUNC1 levels and determined antimicrobial activity against nontypeable Haemophilus
influenzae. An in vitro exposure model was utilized to measure the effect of tobacco exposure on human bronchial
epithelial culture (HBEC) antimicrobial activity against H. influenzae. The direct effects of cigarette and little cigar
smoke exposure on SPLUNC1 function was determined using 24 h growth measurements and LPS binding assays.
Results: H. influenzae growth in cigarette smoker’s sputum was significantly greater compared to never-smokers
sputum over 24 h. HBEC supernatants and lysates contained significantly higher numbers of H. influenzae following
chronic cigarette and little cigar smoke exposure compared to air-exposed controls. Furthermore, SPLUNC1’s
antimicrobial activity and LPS-binding capability against both H. influenzae and P. aeruginosa was attenuated
following cigarette and little cigar exposure.
Conclusions: These data suggest that cigarette and little cigar exposure impairs SPLUNC1’s antimicrobial ability and
that this inhibition may serve as a novel biomarker of harm that can be used to assess the toxicity of commercial
tobacco products.
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Background
Tobacco smoke exposure is a major risk factor for sev-
eral diseases including chronic obstructive pulmonary
disease (COPD) [1] with 251 million cases occurring
world-wide [2]. Tobacco products include cigarettes, ci-
gars, and little cigars. A cigarette consists of a blend of
tobacco encased in paper with a defined composition
specification. In the US, federal regulations have defined
cigars as “any roll of tobacco wrapped in tobacco leaf or
any substance containing tobacco” [3]. Cigars that weigh
less than 3 lbs. per 1000 units are identified as “little ci-
gars”. Importantly, despite being of similar physical ap-
pearance as cigarettes, little cigars have evaded many of
the regulations made for cigarettes. For example, whilst
flavored cigarettes have been banned, flavored little ci-
gars are still commercially available. Further, little cigars
have been perceived as a safer option to cigarette smoke
[4]. However, whilst the effects of little cigars in vivo
have not been studied, recent data suggests that little ci-
gars have a deleterious effect on airway epithelia that is
similar or worse than cigarettes [5].
Tobacco smoke is a major risk factor for mucosal in-
fections including pneumonia, otitis media and peri-
odontitis. Airway surface liquid (ASL) lines the lung’s
mucosal surface and includes a periciliary liquid layer
and an overlying mucus layer. ASL contains approxi-
mately 1000 proteins and peptides that play a variety of
roles including chemical detoxification, protection
against oxidative stress, proteolysis and anti-microbial
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: patrickj.moore1@gmail.com
1Marsico Lung Institute, University of North Carolina at Chapel Hill, 7118A
Marsico Hall, 125 Mason Farm Road, Chapel Hill, NC 27599, USA
Full list of author information is available at the end of the article
Moore et al. Respiratory Research           (2019) 20:94 
https://doi.org/10.1186/s12931-019-1066-2
activities. In vitro, we have previously shown that chronic
little cigar exposure significantly alters the ASL proteome
including changes in proteins involved in the detoxifica-
tion of xenobiotics and proteins required to metabolize re-
action oxygen species [5]. Similarly, in vivo exposure to
cigarettes leads to chronic changes to the ASL proteome
[6]. These changes may be due to inflammation-induced
changes in proteins expression and or altered proteolysis.
These alterations are predicted to (i) impair bacterial
clearance from the lung and (ii) promote colonization of
the lower respiratory tract. Indeed, adult smokers are
susceptible common pathogens such as Haemophilus
influenzae, Pseudomonas aeruginosa and Streptococcus
pneumoniae [7]. COPD lungs are characterized by mucus
dehydration, inflammation and subsequent bacterial infec-
tions that contribute to the progressive and irreversible
airway obstruction and accompanying decline in lung
function [8, 9]. Consistent with their having an innate
defense defect, 60% of COPD patients are chronically col-
onized with bacteria including H. influenzae [10].
Short palate lung and nasal epithelial clone 1
(SPLUNC1; gene name BPIFA1) is a 25 kDa protein that
is secreted into the ASL by the underlying epithelia. A
key component of the innate immune response to infec-
tions, SPLUNC1 has antimicrobial activity against many
Gram-negative bacteria including H. influenzae, P. aeru-
ginosa and the Burkholderia cepacia family [11, 12]. Se-
creted SPLUNC1 levels are diminished in chronic
inflammatory diseases including cystic fibrosis and
asthma [13, 14]. Additionally, SPLUNC1 may also be de-
graded in COPD airways by neutrophil elastase, which
may predispose COPD patients to H. influenzae
colonization, and indeed, SPLUNC1 may be a key innate
defense protein against COPD pathogens [15]. Recently,
we demonstrated that cigarette smoke promoted adduct
binding to SPLUNC1, resulting in a loss of its ability to
regulate ASL hydration [16]. These data suggested that
there may be a “double hit” where SPLUNC1 is inacti-
vated by smoke exposure adducts and/or degraded by
neutrophil elastase. However, the impact of tobacco
smoke on SPLUNC1’s antimicrobial activity against
COPD-relevant pathogens has yet to be determined.
Here, we therefore tested the effect of cigarette and little
cigar exposure on SPLUNC1’s antimicrobial abilities.
Methods
Collection of Normal and smoker sputum samples
Induced sputum samples were collected as per the UNC
IRB protocol #13–3454. Sputum samples were obtained
as described previously [14]. In brief, subjects inhaled 3,
4 and 5% hypertonic saline, each for a 7 min period. To
reduce squamous cell contamination, all subjects per-
formed a 3-step cleansing procedure, including rinsing
and gargling of the mouth with water, clearing of the
throat without coughing, and blowing of their nose. Fol-
lowing cleansing, induced sputum samples were col-
lected into specimen cups using a cough from the chest.
Samples were incubated in Dulbecco’s Phosphate Buff-
ered Saline solution with agitation for 15 min followed
by centrifugation and collection of supernatant. The
demographics and cytology pertaining to the subjects se-
lected for this study are shown in Table 1.
Determination of SPLUNC1 and neutrophil elastase in
sputum samples
Neat sputum samples were denatured in the presence of
2.5% β-mercaptoethanol at 95 °C for ~ 10min and were
subjected to Western blotting. In brief, samples were
transferred to PDVF membranes and blocked using 5%
skimmed milk in Tris-buffered saline with Tween 20
(TBST-T). For detection of neutrophil elastase, mem-
branes were probed using a mouse-monoclonal
anti-hELA2 antibody, raised against residues M1 - N252
(1:3000, R&D systems), primary antibodies were detected
using an anti-mouse horseradish peroxidase (HRP) conju-
gated secondary antibody (Thermo-Fisher Scientific).
Membranes were then stripped, re-blocked and re-probed
for SPLUNC1 using a goat polyclonal hPLUNC1 antibody
raised against residues Q20 - V256 of hPLUNC1 (1:3000,
R&D systems), a secondary anti-goat HRP (Thermo--
Fisher Scientific) conjugated antibody was used for detec-
tion of hPLUNC1. Secondary antibodies were detected by
enhanced chemiluminescence (Thermo-Fisher Scientific).
Human bronchial epithelial cells (HBECs)
Cells obtained from otherwise healthy individuals were
harvested via enzymatic digestion in the presence of
Table 1 Demographics and cytological characteristics of
sputum for the subjects used in this study
Sputum Samples Never-Smokers Smokers
Male/Female 5/1 4/2
Ethinicity (Hispanic/Non- Hispanic) 5/1 0/6
Age at bronch 31 ± 5.19 29 ± 6.9
Pack Years 0.00 ± 0.00 8.03 ± 6.82
BMI 27.86 ± 7.22 23.36 ± 3.57
FVC% 92.5 ± 7.23 101.6 ± 12.1
FEV1 95 ± 8.29 92 ± 11.47
%polymorphonuclear cells 39 ± 9.07 77.9 ± 10.20**
%macrophages 59.5 ± 8.95 20.2 ± 8.90**
%eosinophils 0.35 ± 0.41 0.68 ± 0.95
%lymphocytes 0.00 ± 0.00 0.00 ± 0.00
%bronchial epithelial cells 1.11 ± 1.37 1.20 ± 1.70
%squamous cells 9.22 ± 8.19 28.87 ± 21.43
Data presented are mean ± SD. ** denotes P < 0.001 different to never-
smokers (Mann-Whitney U-test)
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antibiotics from human lungs deemed unsuitable for
transplantation as per the UNC protocol #03–1396 [17].
Freshly isolated HBECs were seeded on 12mm culture
inserts (12 well hanging inserts, 0.4 μm pore; Corning,
USA) and were maintained at the air-liquid interface for
4 weeks in a modified bronchial epithelial growth
medium at 37 °C/5% CO2 in a humidified incubator.
Donor demographics are shown in shown in Table 2.
SPLUNC1 purification
A plasmid containing SPLUNC1 cDNA was transformed
into BL21-Codon Plus competent cells (Agilent Tech-
nologies) and recombinant SPLUNC1 (referred to as
rSPLUNC1) was purified as previously described and
stored at − 80 °C until required [18].
Cigarette smoke exposure
All tobacco smoke was generated using a Borgwaldt LC1
smoke engine using a 1 × 35 ml puff every 30 s with a
butt length of 36 mm (∼13 puffs over ∼5 min). We gener-
ated smoke from Kentucky Research Cigarettes (code
3R4F, Class A cigarettes). Commercially available Marl-
boro and Camel cigarettes were also studied. Since little
cigars were recently found to have a markedly different
chemical profile to cigarettes [5], several types of little
cigars including as Swisher Sweets Original, Swisher
Sweets Strawberry, Captain Black, Cheyenne and
Djarum cigars were studied. For our chronic epithelial
tobacco smoke exposure, HBECs were placed in a cham-
ber that exposed the apical but not the basolateral sur-
face to cigarette smoke. Cells were then exposed to
smoke from 1 cigarette or little cigar or an air control
exposure every day for 5 days and washed with PBS daily
after each exposure, with daily changes of serosal media
[5]. To study rSPLUNC1 under cell-free conditions, the
protein was dissolved in Ringer’s solution and 100 μl of
this solution was placed in a Petri dish and exposed to
tobacco smoke.
HBEC infection and antimicrobial assays
Nontypeable H. influenzae (referred to hereon as H.
influenzae) was grown in brain heart infusion (BHI)
broth supplemented with 1 mg/ml hemin and 10 μg/ml
nicotinamide adenine dinucleotide (sBHI) at 37 °C for
24 h with shaking at 300 rpm. P. aeruginosa strain PAO1
was grown overnight in Luria broth (LB) at 37 °C for 24
h with shaking at 300 rpm. Colony forming units (CFU/
ml) were determined by serial dilution on chocolate agar
plates. The bacterial cultures were adjusted to an optical
density at 600 nm (OD600) of ~ 0.600, and 10
6 CFU/ml
bacteria were apically added to chronically tobacco ex-
posed HBECs for 2 h. Apical supernatants and lysates of
HBECs were collected, serially diluted, plated on LB agar
plates and incubated at 37 °C for 24 h to determine
CFU/ml. For the antimicrobial assay, 106 CFU/ml of H.
influenzae and P. aeruginosa were incubated with to-
bacco exposed and air exposed rSPLUNC1 (10 μM) in
flat clear bottom 96-well plates (Corning Incorporated)
for 24 h at 37 °C. Samples were collected at 24 h, serially
diluted in Ringer’s solution and then plated on LB agar
plates to determine CFU/ml.
Extraction and quantitation of H. influenzae
lipopolysaccharide
Lipopolysaccharide (LPS) was extracted from H. influen-
zae and P. aeruginosa strain 10 (MilliporeSigma) using
the phenol-water method as described previously [19].
Briefly, biomass from 2 chocolate agar plates was har-
vested into PBS after 72 h in culture. Bacteria were
washed 3 times in PBS and collected by centrifugation
(4000 x g for 10 min at 4 °C). The bacterial pellet was
then washed once in deionized H2O and collected by
centrifugation. Following washes, the pellet was resus-
pended in 750 μl of deionized H2O and an equal volume
of 90% phenol (vol/vol; pre-heated to 65 °C; Millipore-
Sigma) was added. The sample was mixed for 1 min
using a vortex mixer and then incubated for 10 min at
65 °C with regular mixing. Following incubation, the
sample was cooled on ice and then centrifuged at 12,000
x g for 10 min at 4 °C. Extracted LPS was then treated
with 200 μg of deoxyribonuclease II (Roche) and ribo-
nuclease A (MilliporeSigma) for 30 min at 37 °C, then
incubated with 200 μg proteinase K (MilliporeSigma) for
1 h at 60 °C and finally heated to 90 °C for 3 min. Ex-
tracted LPS was then quantified using the Purpald assay
as previously described [20].
LPS binding assays
A modified, enzyme-linked immunosorbent assay (ELI-
SA)-based LPS binding method was used to detect inter-
actions between LPS and SPLUNC1 as described
previously [11]. Briefly, 96-well plates were coated over-
night with purified LPS (400 ng) from H. influenzae and
P. aeruginosa strain 10 (MilliporeSigma). Wells were
washed and blocked with 1% bovine serum albumin
(BSA)– PBS for 1 h, then, 400 ng of purified SPLUNC1
was added to each well in triplicate. PBS was used as a
control for this experiment. An antibody specific to hu-
man SPLUNC1 (R&D Systems) diluted 1:5000 with BSA,
was used to detect the LPS-bound SPLUNC1.
Table 2 Demographics of never-smoker HBEC donors used in
this study
Donor Smoking History Age Sex Ethiniticy
1 Never Smoker 48 Male Caucasian
2 Never Smoker 58 Female Caucasian
3 Never Smoker 69 Male Caucasian
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Horseradish peroxidase-conjugated anti-goat antibody
was used as the secondary antibody to detect binding
rSPLUNC1. Enzyme activity was detected using a TMB
Ultra 1-step assay (Pierce Biotechnology) and reaction
was stopped with H2SO4 (Fisher). Absorbance was de-
tected at OD450nm in a BioTek spectrophotometer
(BioTek).
Statistical analysis
The number of replicates performed per experiment is
noted in the respective figure legends. All experiments
were repeated on ≥3 separate occasions. All experiments
that were conducted using HBECs were repeated using 3
different donors on separate occasions with triplicates
per donor unless otherwise indicated. Data are shown as
mean ± standard error. Differences between means were
tested for statistical significance using Mann-Whitney
t-test, analysis of variance (ANOVA), Kruskal-Wallis test
with Dunn’s multiple comparison and two-way ANOVA
with Tukey’s multiple comparisons test as appropriate.
Statistical analysis was performed using GraphPad Prism
7.0 with p < 0.05 considered as being significant.
Results
Smokers sputum contained altered cytological
measurements
The demographics and cytology pertaining to the sub-
jects selected for this study were summarized in Table 1.
Cigarette smokers had an 8.03 ± 6.82 pack year smoking
history. All smokers were healthy and there was no sig-
nificant difference in FVC% and FEV1% between the
groups. In contrast, sputum cytology analysis revealed a
statistically significant difference in polymorphonuclear
cells and macrophages in smokers’ sputum (Table 1).
H. influenzae proliferates in cigarette-smokers sputum
We first determined whether SPLUNC1 was present in
smoker’s sputum. Consistent with our goal of recruiting
“healthy smokers”, we detected no significant difference
in SPLUNC1 levels in never-smokers’ and smokers’ spu-
tum (Fig. 1). Similarly, neutrophil elastase was present in
both groups and was also not significantly different (Fig.
1). We next interrogated the antimicrobial activity of
smokers’ vs. never-smokers’ airway secretions by cultur-
ing them with H. influenzae for 24 h. We found that
Fig. 1 SPLUNC1 protein levels are similar in smokers’ and never-smokers’ sputum. Representative Western blots showing endogenous expression
of SPLUNC1 (a) and neutrophil elastase (c) in never smoker and smokers sputum from n = 6 donors per group. Membranes were probed for
SPLUNC1 prior to stripping and re-probing for neutrophil elastase. Bar graphs showing mean densitometry of SPLUNC1 (b) and neutrophil
elastase (d) protein abundance in never smokers and smokers sputum
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significantly more H. influenzae grew in smoker’s spu-
tum compared to never-smoker’s sputum (Fig. 2).
Chronic cigarette and Little cigar smoke exposures cause
increased H. influenzae growth
To assess the impact of different tobacco products on
human airway epithelia, we chronically exposed HBECs
to a commercial cigarette (Marlboro) and two little cigar
products (Cheyenne and Swisher Strawberry) or air
(control) for 5 days. We have previously observed that
chronic (5 day) exposure from either cigarettes or little
cigars did not cause gross cellular abnormalities [5] and
consistent with this observation, all cultures remained
viable throughout the exposure period. After the chronic
exposure, HBECs were infected mucosally with H. influ-
enzae for 2 h, then lavages and whole cell lysates were
collected after incubation. Interestingly H. influenzae
colonization of tobacco smoke-exposed HBECs was sig-
nificantly increased compared to the air-exposed culture
(Fig. 3a). In addition, we also recovered significantly
higher numbers of internalized H. influenzae from ly-
sates of tobacco-exposed cultures (Fig. 3b).
Tobacco exposure to SPLUNC1 attenuates bacteriostatic
ability
We have previously demonstrated that SPLUNC1’s abil-
ity to regulate ASL homeostasis was attenuated follow-
ing exposure to cigarette smoke [16]. However, the
effects of cigarette smoke on SPLUNC1’s antimicrobial
activity have not yet been determined. Therefore, to test
whether cigarette smoke from Kentucky research
cigarettes altered SPLUNC1’s antimicrobial functions,
we used a physiological concentration (10 μM) of
rSPLUNC1 [21]. After exposure to air or tobacco smoke,
we incubated rSPLUNC1 with H. influenzae for 24 h.
rSPLUNC1’s antimicrobial activity was attenuated and
H. influenzae growth was significantly greater in the
presence of tobacco exposed-SPLUNC1 compared to
air-exposed SPLUNC1 (Fig. 4a). To determine whether
other tobacco products also attenuated SPLUNC1’s anti-
microbial functions, we exposed rSPLUNC1 to commer-
cial cigarettes including Marlboro and Camel cigarettes,
as well as little cigars such as Djarum, Cheyenne,
Swisher Sweets Original, Swisher Sweets Strawberry, and
Captain Black. Consistent with the effects seen with
Kentucky research cigarettes, commercial tobacco prod-
ucts also significantly attenuated SPLUNC1’s antimicro-
bial activity (Fig. 4b). To test whether this effect
extended beyond that seen with H. influenzae, we also
tested the ability of tobacco smoke to impair SPLUNC1’s
antimicrobial actions against P. aeruginosa [22]. Similar
to the results obtained with H. influenzae, SPLUNC1’s
antimicrobial activity against P. aeruginosa was also at-
tenuated following tobacco exposure (Fig. 4c, d), sug-
gesting that this phenomenon may be relevant to
multiple Gram-negative organisms.
SPLUNC1 LPS-binding properties are reduced after
cigarette and Little cigar smoke exposure
SPLUNC1 has previously been shown to bind LPS from
different Gram-negative bacteria, which may be linked
to its antimicrobial activities [11]. However, the effect of
tobacco smoke exposure on SPLUNC1-LPS interactions
has not been studied. We therefore purified LPS from
both H. influenzae and P. aeruginosa and determined
SPLUNC1-LPS binding using an ELISA-based assay
[23]. Consistent with previous observations [11], we
found that SPLUNC1 bound LPS in a dose-dependent
fashion (Fig. 5). Indeed, following exposure to Kentucky
research cigarettes, commercial cigarettes (Camel and
Marlborough) and little cigars (Djarum, Cheyenne,
Swisher Sweets and Captain Black), we observed a sig-
nificant reduction in SPLUNC1 binding to LPS purified
from H. influenzae and P. aeruginosa (Fig. 5a, b).
Discussion
ASL contains multiple anti-microbial proteins and pep-
tides, as well as proteases and mucins, all of which help
to clear inhaled bacteria, and it is likely that the system
redundancy is an important feature to combat against
bacterial colonization. It was recently demonstrated that
44 proteins had altered abundance in sputum from
cigarette smokers compared to never-smokers, including
the MUC5AC mucin and a number of antioxidant and
xenobiotic metabolizing proteins [24]. These authors
Fig. 2 Cigarette smoker’s sputum has increased H. influenzae
growth. Sputum was obtained from never-smokers and smokers (n
= 6 per group). 105 CFU H. influenzae were added to 20 μl of Sputum
and CFUs were measured 24 h later. **p < 0.001 different to never-
smokers (Mann-Whitney U-test)
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also detected increases in anti-microbial proteins such
as lysozyme and lactotransferrin in cigarette smokers
sputum [24]. Despite their being numerous proteins in
the ASL, we and others postulate that SPLUNC1 is critically
important for innate defense. For example, it has previously
been demonstrated that SPLUNC1 knockout mice exhibited
increased susceptibility to infection and failed to clear H.
influenzae and P. aeruginosa from their lungs [15, 25]. Jiang
et al. further speculated that SPLUNC1 plays a key role in
preventing H. influenzae colonization of the lung, and that
SPLUNC1’s activity is impaired in COPD patients [15].
Based on these data, we used SPLUNC1 as a representative
anti-microbial agent and tested its sensitivity to tobacco
smoke exposure. We found that both never-smokers and
cigarette smokers’ sputum contained similar levels of
SPLUNC1 protein (Fig. 1). Consistent with neutrophil elas-
tase being the predominant protease that degrades
SPLUNC1 in ASL [15, 26] total neutrophil elastase protein
levels were also similar between never-smokers and smokers
(Fig. 1). These data are similar to the Reidel study where
Fig. 3 Tobacco smoke exposure leads to increased H. influenzae colonization. HBECs obtained from normal donors were exposed to air or
tobacco smoke from Marlboro cigarettes, Cheyenne little cigars and Swisher Sweets Strawberry little cigars, once a day for 5 days. 20 μl of H.
influenzae at 106 CFU/ml were added apically to HBECs for 2 h at 37 °C/5% CO2. a Apical supernatants and (b) lysates were collected, serially
diluted, plated on LB agar plates and incubated at 37 °C for 48 h to determine colony-forming units (CFU) for bacterial load (all n = 9). Statistically
significant differences were measured using the Kruskal-Wallis test. **p < 0.001, ***p < 0.0001 different to air control
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they also found no change in SPLUNC1 and neutrophil
elastase despite seeing a similar increase in sputum neutro-
phil levels [24] (Table 1).
Despite our observing no change in SPLUNC1 levels,
and other researchers finding an increase in
anti-microbial proteins in smoker’s sputum, we observed
a significant increase in H. influenzae growth in
smokers’ sputum (Fig. 2), suggesting that innate immune
defense was impaired and we went on to study this
phenomenon in more detail in vitro. It has recently been
demonstrated that bronchoalveolar lavage (BAL) from
smokers had increased Staphylococcus aureus and P.
aeruginosa growth compared to never-smokers’ BAL
Further, S. aureus and P. aeruginosa exhibited increased
rates of biofilm formation in smokers’ BAL compared to
never-smokers’ BAL [27]. Taken together, these data
suggest that smoker’s antimicrobial defenses were im-
paired. Using a proteomic approach, Qu et al. found that
H. influenzae upregulated antioxidant/stress response
proteins as well as proteins involved in the uptake of
minerals such as iron and zinc [28]. These metabolic ad-
aptations reveal critical virulence factors that enable H.
influenzae survival in oxidative and nutritionally limited
environment of the COPD lung. In the current study, we
utilized sputum from non-smokers who were all
never-smokers and healthy current smokers and looked
primarily for sensitivity to H. influenzae.
It has previously been postulated that H. influenzae
colonization contributes to the pathogenesis of COPD
[29]. Crucially, H. influenzae can alter its genome during
Fig. 4 Tobacco smoke exposure reduces SPLUNC1 bacteriostatic activity. a, c 10 μM of SPLUNC1 or Kentucky cigarette-exposed SPLUNC1
dissolved in Ringer’s solution were co-incubated with 106 of H. influenzae or P. aeruginosa for 24 h (all n = 3 per group). b, d H. influenzae or P.
aeruginosa were co-incubated with 10 μM of SPLUNC1 or tobacco-exposed SPLUNC1 for 24 h; Camel, Marlboro, Djarum, Cheyenne, Swisher
Sweets, Swisher Sweets Strawberry, and Captain Black (all n = 3 per group). Statistically significant differences were measured using Kruskal-Wallis
test. *p < 0.05, **p < 0.01, ***p < 0.001 different to control
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airway colonization, leading to changes in virulence,
which may facilitate its ability to adapt to the harsh en-
vironment of the lung. For example, Pettigrew et al. ob-
served large-scale genome rearrangement between the
loci for HMW1 and HMW2 adhesins, which could influ-
ence how H. influenzae can attach to epithelia [30]. In
addition, changes in simple sequence repeats were the
main driver of change during H. influenzae colonization
of the COPD lung [30]. Chronic colonization/adaptation
of H. influenzae in COPD airways has been well
documented, although, the underlying host defects that
contribute to this phenomenon are poorly understood.
Conversely, the airway microbiome of “healthy smokers”
is less studied. However, COPD patients have a different
lower airways microbiota than both never-smokers and
smokers. This suggests that this is an evolving situation
and that the lower airway microbiota changes with the
development of COPD and with its progression [31].
In addition to our sputum studies, we also utilized an
in vitro chronic tobacco smoke exposure system where
Fig. 5 Tobacco smoke reduces SPLUNC1’s ability to bind LPS. Graphs show Non-linear regression fit generated from one site specific binding of
LPS derived from either H. influenzae (a) or P. aeruginosa (b) with 2 fold dilutions of SPLUNC1, cigarette and tobacco smoke exposed SPLUNC1
dissolved in Ringer’s solution to commercial cigarettes and several little cigars (all n = 9 per group). Statistically significant differences were
measured using Kruskal-Wallis test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 different to Air + SPLUNC1
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HBECs were cultured for up to 8 weeks and maintained
similar properties as native airway epithelia including
similar density of ciliated cells and an isotonic ASL that
mimic in vivo, suggesting that their use is valid [32].
Using this model, we previously exposed the apical but
not basolateral membranes of primary HBECs to Ken-
tucky research cigarettes as well as commercial ciga-
rettes and little cigars [5]. We found that chronic
tobacco exposure significantly changed gene expression,
reduced transepithelial electrical resistance, increased
interleukin (IL)-8 secretion and decreased cilia length
[5]. However, after chronic tobacco exposure, the cul-
tures remained viable and capable of maintaining an (al-
beit diminished) ASL. Similarly, cigarette smoke
condensate suppressed IL-6, IL-8 and mitogen activated
protein kinase responses to H. influenzae in the adeno-
carcinoma A549 alveolar cell line [33]. However, A549
cells do not differentiate into ciliated/goblet cells and
may not fully reprise the pseudostratified epithelia seen
in the conducting airways. Therefore, we postulate that
having a well-differentiated cell culture model is crucial
in order to determine the clinical effects of chronic to-
bacco exposure on host cell response to bacterial
colonization. To further test the hypothesis that tobacco
smoke attenuates innate antimicrobial activity, we uti-
lized this chronic exposure system. Similar to our obser-
vations using ex vivo patient samples (Figs. 1 and 2), we
observed significantly greater bacterial numbers in
chronically tobacco-exposed HBECs (Fig. 3a, b), suggest-
ing that tobacco smoke impairs antimicrobial activity
within the ASL. To the best of our knowledge, this is the
first time that this model has been used to observe the
effects of chronic tobacco exposure on H. influenzae
colonization of HBECs.
To better the understand effect of cigarette and little
cigar smoke exposures on SPLUNC1, using a cell-free ap-
proach, we exposed recombinant SPLUNC1 to cigarette
smoke and tobacco exposure as previously described [34],
and then tested its antimicrobial activity against H. influ-
enzae and P. aeruginosa. Interestingly, we observed a sig-
nificant loss of SPLUNC1’s antimicrobial activity after
both cigarette and little cigar smoke exposures (Fig. 4a, b).
However, SPLUNC1’s antimicrobial function was similarly
impaired after exposure to tobacco smoke from both ciga-
rettes and little cigars (Fig. 4). It has previously been pro-
posed that SPLUNC1 exerts its antimicrobial effects by
binding LPS and disrupting bacterial cell walls. Consistent
with previous observations [11], we found that SPLUNC1
dose-dependently bound to both H. influenzae and P. aer-
uginosa LPS (Fig. 5). However, after cigarette smoke and
little cigar exposure, SPLUNC1-LPS interactions were also
significantly attenuated (Fig. 5).
In our previous study, we found that both cigarette
and little cigar exposure affected gene expression.
Further, using proteomics, we found that 50 secreted/
ASL proteins were significantly altered by cigarette ex-
posure, whilst 132 proteins were altered in the little cigar
exposure groups [5]. Many of these proteins were in-
volved in detoxification of reactive oxygen species, me-
tabolism of xenobiotics, vesicle transport and cell
migration/would healing, which is consistent with re-
peated exposure to a toxic insult [5]. However, despite
the disparity in changes between cigarette and little cigar
smoke exposures, we did not observe significant changes
in known antimicrobial peptides/proteins and secreted
SPLUNC1 levels were not different after chronic tobacco
smoke exposure [5], which is similar to our ex vivo data
(Fig. 1). We have previously demonstrated that reactive
aldehydes present in cigarette smoke bind to SPLUNC1’s
two cysteine residues, resulting in an alteration of
SPLUNC1’s quaternary structure via disruption of the di-
sulfide bonds [16]. This interaction abrogates SPLUNC1’s
ability to bind to and regulate the epithelial Na+ channel,
ENaC [16]. Although the role of these cysteine residues in
SPLUNC1’s antimicrobial function is unclear, we
hypothesize that disruption of the disulfide bond may play
a key role in the observed loss of SPLUNC1’s bacterio-
static activity by preventing LPS-binding.
Although the hazardous effects of cigarette smoke on
lung health have been well studied [35, 36], there is a
lack of knowledge regarding the effects of little cigars on
lung health, and in vivo data is critically lacking. More-
over, the sales of little cigars are on the rise, especially
amongst young adults, where they are perceived as a
safer alternative to cigarettes [37]. Further, in some
states, including North Carolina, South Carolina and
Georgia, little cigars are taxed at a significantly lower
rate than cigarettes and are hence seen as a cheaper al-
ternative to cigarettes [38]. However, building on our
previous studies [5, 39], our data demonstrate that little
cigars do constitute a reduced risk of tobacco exposure
that equally predispose the airways to risk of bacterial
infections.
Conclusions
In conclusion, our results advance the understanding of
how multiple, relevant commercial brands of tobacco
impair SPLUNC1’s antimicrobial function. Due to the
importance of bacterial clearance for lung health, our
data suggest that the loss of antimicrobial function after
tobacco exposure may predispose smokers to infections
and that little cigar use may similarly put smokers at risk
of chronic lung infections.
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